How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,362 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

10321. Psychological responses to genetic testing Full Text available with Trip Pro

Psychological responses to genetic testing 9522800 1998 04 16 2018 11 13 0959-8138 316 7132 1998 Feb 28 BMJ (Clinical research ed.) BMJ The new genetics. Psychological responses to genetic testing. 693-6 Marteau T M TM Psychology and Genetics Research Group, United Medical School, Guy's Hospital, London. Croyle R T RT eng Wellcome Trust United Kingdom Journal Article Research Support, Non-U.S. Gov't Review England BMJ 8900488 0959-8138 AIM E IM BMJ. 1998 Aug 8;317(7155):417 9694776 BMJ. 1998 (...) Aug 15;317(7156):471 9703537 Attitude to Health Decision Making Family Genetic Diseases, Inborn Genetic Testing methods psychology Humans Interpersonal Relations Public Opinion Uncertainty 34 57756 Genetics and Reproduction KIE BoB Subject Heading: genetic counseling KIE BoB Subject Heading: genetic screening Full author name: Marteau, Theresa M Full author name: Croyle, Robert T 1998 4 2 1998 4 2 0 1 1998 4 2 0 0 ppublish 9522800 PMC1112686 Am J Hum Genet. 1994 Oct;55(4):626-37 7942840 Am J Med

1998 BMJ : British Medical Journal

10322. Withholding and withdrawal of life support from critically ill patients. Full Text available with Trip Pro

Withholding and withdrawal of life support from critically ill patients. 9426480 1998 02 10 2018 11 13 0093-0415 167 6 1997 Dec The Western journal of medicine West. J. Med. Withholding and withdrawal of life support from critically ill patients. 411-6 Luce J M JM Department of Medicine, University of California, San Francisco, USA. eng Journal Article Review United States West J Med 0410504 0093-0415 AIM E IM Critical Illness therapy Decision Making Dissent and Disputes Empirical Research (...) Ethics, Medical Euthanasia, Passive Group Processes Humans Life Support Care legislation & jurisprudence standards Physician-Patient Relations Resource Allocation Resuscitation Orders legislation & jurisprudence Withholding Treatment 32 63362 Death and Euthanasia Society of Critical Care Medicine KIE BoB Subject Heading: allowing to die Full author name: Luce, John M 1998 1 14 1998 1 14 0 1 1998 1 14 0 0 ppublish 9426480 PMC1304720 N Engl J Med. 1990 Feb 1;322(5):309-15 2296273 JAMA. 1990 Feb 2;263(5

1997 Western Journal of Medicine

10323. Effects of computerized guidelines for managing heart disease in primary care. Full Text available with Trip Pro

decisions for individual patients. CONCLUSIONS: Care suggestions generated by a sophisticated electronic medical record system failed to improve adherence to accepted practice guidelines or outcomes for patients with heart disease. Future studies must weigh the benefits and costs of different (and perhaps more Draconian) methods of affecting clinician behavior.[PUBLICATION ABSTRACT] Author supplied keywords Cite CITATION STYLE APA Tierney MD, W. M., Overhage MD, PhD, J. M., Murray D Pharm, MPH, M. D (...) Effects of computerized guidelines for managing heart disease in primary care. Effects of computerized guideline... preview & related info | Mendeley Papers People Groups Search Search Search Journal Article Effects of computerized guidelines for managing heart disease in primary care Tierney MD W Overhage MD, PhD J Murray D Pharm, MPH M et al. See more Journal of General Internal Medicine (2003) 18(12) 967-976 DOI: N/A Citations Citations of this article 1 Readers Mendeley users who have

2003 Journal of General Internal Medicine Controlled trial quality: uncertain

10324. Assessment and Management of Acute Pain in Adult Medical Inpatients

be hard to ascertain. Data on the course and treatment of pain in medical inpatients are absent. Little is known about how intravenous opioid therapy, considered the treatment of choice for patients with severe, acute pain, is used on a medical service. In contrast to the post-operative setting, on a medical service the patient’s course is less predictable, making it difficult to establish standards for when and how to change pain therapy and how to deliver it. Textbooks and professional societies (...) medicine, 2 general surgery, 2 specialty surgery, 1 oncology, and 1 mixed oncology/general medicine) at Mount Sinai Hospital in New York. Usual care required that pain be assessed at least once per shift using a 4­ point scale. The intervention included, in phases: education, standardized pain assessment using a 1- or 4-item (enhanced) pain scale, audit and feedback of pain scores to nursing staff, and a computerized decision support system to guide analgesic prescribing. The enhanced pain assessment

2008 Veterans Affairs Evidence-based Synthesis Program Reports

10325. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant Full Text available with Trip Pro

Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant Yen E F, Hardinger K, Brennan DC, Woodward R S, Desai N M, Crippin J S, Gage B F, Schnitzler M A Record Status This is a critical abstract (...) immunosuppressive medications to the life of a renal allograft would diminish the risks of transplant failure and death in those unable to otherwise afford therapy. They suggested that it would be wise to prospectively follow changes in outcomes following a change in policy to lifetime immunosuppression coverage. Source of funding Supported in part by an NIH grant and by the Washington University General Clinical Research Center. Bibliographic details Yen E F, Hardinger K, Brennan DC, Woodward R S, Desai N M

2004 NHS Economic Evaluation Database.

10326. Intensive insulin therapy in the medical ICU – not so sweet?

Professor, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA Published online: 10 th August 2007 This article is online at http://ccforum.com/content/11/4/311 © 2007 BioMed Central Ltd Critical Care 2007, 11: 311 (DOI 10.1186/cc5953) Expanded Abstract Citation Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N.Engl.J.Med 2006 (...) to avoid this treatment modality in those with hepatic or renal failure. Competing interests The authors declare no competing interests. References 1. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy

2007 Critical Care - EBM Journal Club

10327. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: results from a decision analytic model

analytic model Aziz M, Mehringer A M, Mozurkewich E, Razik G N Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The present study compared two maintenance treatments for recurrent depression in elderly patients who responded (...) effects. For this promising treatment to be adopted more widely, it will be necessary to increase the number of facilities that provide ECT. It will also be necessary to minimise the stigma associated with its use by offering teleconferences, symposiums, and presentations. Finally, more research will be needed in the area of MECT to answer many of the unresolved questions related to its use. Source of funding None stated. Bibliographic details Aziz M, Mehringer A M, Mozurkewich E, Razik G N. Cost

2005 NHS Economic Evaluation Database.

10328. A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany

A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany Beard A M, Maciver F, Clouth J, Ruther E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED (...) , Clouth J, Ruther E. A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany. European Journal of Health Economics 2006; 7: 165-172 PubMedID DOI Other publications of related interest Because readers are likely to encounter and assess individual publications, NHS EED abstracts reflect the original publication as it is written, as a stand-alone paper. Where NHS EED abstractors are able to identify positively that a publication is significantly

2006 NHS Economic Evaluation Database.

10329. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy

in their own eligible populations. In the absence of specific internal data on resistance, inpatient E. coli susceptibility data for uncomplicated UTI is a reasonable basis for decision-making. The authors recommended further research on the identification of outpatient resistance rates to help decision-makers make more informed decisions. Their discussion also highlighted areas where further information is needed. Source of funding Funded by Bayer Pharmaceuticals Inc. Bibliographic details Perfetto E M (...) Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy Perfetto E M, Keating K, Merchant S, Nichols B R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract

2004 NHS Economic Evaluation Database.

10330. The medical treatment of ocular myasthenia

; DOI: 10.1212/01.wnl.0000263481.14289.90 Citation Manager Formats Make Comment See Comments Downloads 15886 Share Abstract Objective: To perform a systematic review of the relevant literature and to provide evidence-based guidelines for the medical treatment of ocular myasthenia. Methods: Medline, EMBASE, and the Cochrane Neuromuscular Disease Group Register were searched for articles of possible relevance to the medical treatment of ocular myasthenia. The titles and abstracts of all articles (...) the efficacy of azathioprine suggest that these agents may be effective in reducing the risk of progression from ocular to generalized MG (Class IV). Recommendations. For patients with ocular myasthenia, the evidence does not support or refute the use of corticosteroids and/or azathioprine to reduce the risk of progression to generalized MG (Level U). The decision to use such agents should be weighed against the potential for harmful side effects of these medications. Furthermore, it is not possible

2007 American Academy of Neurology

10331. Improving Medical Implant Performance Through Retrieval Information: Challenges and Opportunities

, it has exercised such authority only rarely. The FDA's quality system and medical device reporting requirements may negatively influence manufacturers' decisions about whether to conduct such research voluntarily. If reported to the FDA, manufacturers may fear that proprietary retrieval information may be disclosed to the public if it does not qualify as trade secret or confidential commercial data. On the other hand, the expansion of Federal and State privacy protections makes it difficult (...) understand how to establish policy. The medical community should have all the information given to patients and policymakers, but they need still more information. Specifically, practicing physicians must decide which of the competing devices to use in a specific patient. To make that decision, they need comparative information about device models. Data on performance, with appropriate denominators, should help inform their choices. An educational program for physicians should stress that part

2000 NIH Consensus Statements

10332. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy

A L, Buesterien K, Sullivan E M, Tanio C P, Strauss M J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Three therapies for benign prostatic hyperplasia (BPH) were compared. The three therapies were medical therapy (alpha-blocker (...) details Manyak M J, Ackerman S J, Blute M L, Rein A L, Buesterien K, Sullivan E M, Tanio C P, Strauss M J. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. Journal of Endourology 2002; 16(1): 51-56 PubMedID DOI Other publications of related interest Ackerman SJ, Rein AL, Blute ML, et al. Cost effectiveness of microwave therapy in patients with benign prostatic hyperplasia: methods. Urology 2000;56

2002 NHS Economic Evaluation Database.

10333. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?

Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Ledwidge M, Barry M, Cahill J, Ryan E, Maurer B, Ryder M, Travers B, Timmons L, McDonald K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) from the Irish heart Foundation and Servier Laboratories, Ireland. Bibliographic details Ledwidge M, Barry M, Cahill J, Ryan E, Maurer B, Ryder M, Travers B, Timmons L, McDonald K. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? European Journal of Heart Failure 2003; 5(3): 381-389 PubMedID Other publications of related interest McDonald KM, Ledwidge M, Cahill J, et al. Heart failure managements: multidisciplinary care has intrinsic benefit above

2003 NHS Economic Evaluation Database.

10334. Feasibility and effects of decision aids

that different types of decision aids make to the quality of health care. Funding Dutch Cancer Society. Bibliographic details Molenaar S, Sprangers M A, Postma-Schuit F C, Rutgers E J, Noorlander J, Hendriks J, De Haes H C. Feasibility and effects of decision aids. Medical Decision Making 2000; 20(1): 112-127 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Clinical Trials as Topic; Decision Making; Decision Support Techniques; Feasibility Studies; Female; Humans; Male; Patient Education (...) Feasibility and effects of decision aids Feasibility and effects of decision aids Feasibility and effects of decision aids Molenaar S, Sprangers M A, Postma-Schuit F C, Rutgers E J, Noorlander J, Hendriks J, De Haes H C Authors' objectives To investigate whether decision aids affect the decision-making process and patients' outcomes. Searching The authors searched MEDLINE from 1993 to August 1998 using the index terms 'decision making', 'decision support techniques', 'patient participation

2000 DARE.

10335. Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia Full Text available with Trip Pro

recommendations for further research or changes to practice. Source of funding None stated. Bibliographic details Ost D E, Hall C S, Joseph G, Ginocchio C, Condon S, Kao E, Larusso M, Itzla R, Fein A M. Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2003; 168(9): 1060-1067 PubMedID DOI Indexing Status Subject indexing assigned by NLM MeSH Anti-Bacterial Agents /economics /therapeutic use; Bronchoalveolar (...) Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia Ost D E, Hall C S, Joseph G, Ginocchio C, Condon S, Kao E, Larusso M, Itzla R, Fein A M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract

2003 NHS Economic Evaluation Database.

10336. Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis

Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis Fendrick A M, Bandekar R R, Chernew M E, Scheiman J M Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) of Michigan. Bibliographic details Fendrick A M, Bandekar R R, Chernew M E, Scheiman J M. Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis. Arthritis and Rheumatism (Arthritis Care and Research) 2002; 47(1): 36-43 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Anti-Inflammatory Agents, Non-Steroidal /economics /therapeutic use; Cost-Benefit Analysis; Decision Support Techniques; Drugs, Generic /economics /therapeutic use

2002 NHS Economic Evaluation Database.

10337. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis

Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis Bloom B S, Fendrick A M, Chernew M E, Patel P Record Status (...) be aggressively pursued when available. Source of funding Supported by an unrestricted research grant to the University of Pennsylvania from SmithKline Beecham Inc, Philadelphia, PA, USA. Bibliographic details Bloom B S, Fendrick A M, Chernew M E, Patel P. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. American Journal of Kidney Diseases 1996; 27(5): 687-694 PubMedID Indexing Status Subject indexing assigned

1996 NHS Economic Evaluation Database.

10338. Justification of intervention for limb-threatening ischemia: a surgical decision analysis

, Medical Research Service, Department of Veterans Affairs. Bibliographic details Brothers T E, Rios G A, Robison J G, Elliott B M. Justification of intervention for limb-threatening ischemia: a surgical decision analysis. Cardiovascular Surgery 1999; 7(1): 62-69 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Aged; Amputation; Arterial Occlusive Diseases /economics /surgery; Blood Vessels /transplantation; Decision Trees; Female; Humans; Ischemia /economics /surgery; Leg /blood supply (...) Justification of intervention for limb-threatening ischemia: a surgical decision analysis Justification of intervention for limb-threatening ischemia: a surgical decision analysis Justification of intervention for limb-threatening ischemia: a surgical decision analysis Brothers T E, Rios G A, Robison J G, Elliott B M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods

1999 NHS Economic Evaluation Database.

10339. Human papillomavirus testing for triage of women referred because of abnormal smears: a decision analysis considering outcomes and costs

Human papillomavirus testing for triage of women referred because of abnormal smears: a decision analysis considering outcomes and costs Human papillomavirus testing for triage of women referred because of abnormal smears: a decision analysis considering outcomes and costs Human papillomavirus testing for triage of women referred because of abnormal smears: a decision analysis considering outcomes and costs Meerding W J, van Ballegooijen M, Burger M P, Marle M E, Quint W G, Habbema J D Record (...) of those HR-HPV types that are predictive for high-grade SIL. Further, the role of age as a possible additional triage criterion should be explored in populations with mild cytology. Source of funding Funded by grant OG91-053 from the Fund for Investigative Medicine of the National Health Insurance Council. Bibliographic details Meerding W J, van Ballegooijen M, Burger M P, Marle M E, Quint W G, Habbema J D. Human papillomavirus testing for triage of women referred because of abnormal smears

2002 NHS Economic Evaluation Database.

10340. Internal derangements of the shoulder: decision tree and cost-effectiveness analysis of conventional arthrography, conventional MRI, and MR arthrography

Internal derangements of the shoulder: decision tree and cost-effectiveness analysis of conventional arthrography, conventional MRI, and MR arthrography Internal derangements of the shoulder: decision tree and cost-effectiveness analysis of conventional arthrography, conventional MRI, and MR arthrography Internal derangements of the shoulder: decision tree and cost-effectiveness analysis of conventional arthrography, conventional MRI, and MR arthrography Oh C H, Schweitzer M E, Spettell C M (...) on the accuracy of single- and double-contrast conventional arthrography. Implications of the study The use of conventional arthrography performed with admixed diluted gadolinium, which if negative, is followed by MRI, is both more expensive and more effective than conventional MRI. The added costs are reduced as the prevalence of labral tears increase in the population. Source of funding Supported by the RSNA Research and Education Fund. Bibliographic details Oh C H, Schweitzer M E, Spettell C M. Internal

1999 NHS Economic Evaluation Database.

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>